The Fight for Survival: Josh Hardy's Story

The Fight for Survival: Josh Hardy's Story Play

March 12 (Bloomberg) -- Bloomberg's Meg Tirrell and Ken Moch, president and CEO of Chimerix, discuss Chimerix reaching an agreement with the FDA for pilot trial initiation of open-label brincidofovir for treatment of adenovirus infections in immunocompromised patients. They speak with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

  • On Air Now

    Street Smart with Trish Regan Watch Now

  • Next

    Taking Stock with Pimm Fox

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus